O^6-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma
-
- SONODA Yukihiko
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- YOKOSAWA Michiko
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- SAITO Ryuta
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- KANAMORI Masayuki
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- YAMASHITA Yoji
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- KUMABE Toshihiro
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- WATANABE Mika
- Pathological Division, Tohoku University Hospital
-
- TOMINAGA Teiji
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
Search this Article
Author(s)
-
- SONODA Yukihiko
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- YOKOSAWA Michiko
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- SAITO Ryuta
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- KANAMORI Masayuki
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- YAMASHITA Yoji
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- KUMABE Toshihiro
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
-
- WATANABE Mika
- Pathological Division, Tohoku University Hospital
-
- TOMINAGA Teiji
- Department of Neurosurgery, Tohoku University Graduate School of Medicine
Journal
-
- Int J Clin Oncol
-
Int J Clin Oncol 15(4), 352-358, 2010-08-01
References: 38
-
1
- Glioblastoma multiforme : a clinical survey
-
ROTH JG
J Neurosurg 17, 736-750, 1960
Cited by (1)
-
2
- Ten-year survival among patients with supratentorial astrocytomas grade III and IV
-
SALFORD LG
J Neurosurg 69, 506-509, 1988
Cited by (1)
-
3
- Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome
-
DEVAUX BC
J Neurosurg 78, 767-775, 1993
Cited by (1)
-
4
- Long-term survival in patients with supratentorial glioblastoma
-
SALVATI M
J Neurooncol 36, 61-64, 1998
Cited by (1)
-
5
- Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
-
SCOTT JN
Ann Neurol 46, 183-188, 1999
Cited by (1)
-
6
- The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme
-
SHINOJIMA N
J Neurosurg 101, 219-226, 2004
Cited by (1)
-
7
- Long-term survival with glioblastoma multiforme
-
KREX D
Brain 130, 2596-2606, 2007
Cited by (1)
-
8
- Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea-based chemotherapy
-
KAMIRYO T
Neurosurgery 54, 349-357, 2004
Cited by (1)
-
9
- Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
-
ESTELLER M
Cancer Res 59, 793-797, 1999
Cited by (1)
-
11
- Long-term survivors of glioblastoma : clinical features and molecular analysis
-
SONODA Y
Acta Neurochir (Wien) 151, 1349-1358, 2009
Cited by (1)
-
12
- Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas
-
NAKASU S
J Neurooncol 70, 333-340, 2004
Cited by (1)
-
13
- Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas
-
BRELL M
Clin Cancer Res 11, 5167-5174, 2005
Cited by (1)
-
14
- Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide
-
CHINOT OL
J Clin Oncol 25, 1470-1475, 2007
Cited by (1)
-
15
- MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities
-
CRINIERE E
J Neurooncol 83, 173-179, 2007
Cited by (1)
-
16
- Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas : proposal of a feasible immunohistochemical approach
-
CAPPER D
Acta Neuropathol 115, 249-259, 2008
Cited by (1)
-
17
- Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas
-
GRASBON-FRODL EM
Int J Cancer 121, 2458-2464, 2007
Cited by (1)
-
18
- MS-MLPA : an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas
-
JEUKEN JW
Lab Invest 87, 1055-1065, 2007
Cited by (1)
-
19
- Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme : observer variability and lack of association with patient survival impede its use as clinical biomarker
-
PREUSSER M
Brain Pathol 18, 520-532, 2008
Cited by (1)
-
20
- MGMT promoter hypermethylation in a series of 104 glioblastomas
-
MELLAI M
Cancer Genomics Proteomics 6, 219-227, 2009
Cited by (1)
-
21
- O6-Methylguanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolomide plus cisplatin in glioblastoma multiforme
-
BALANA C
Clin Cancer Res 9, 1461-1468, 2003
Cited by (1)
-
22
- Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas
-
BLANC JL
J Neurooncol 68, 275-283, 2004
Cited by (1)
-
23
- CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas
-
PAZ MF
Clin Cancer Res 10, 4933-4938, 2004
Cited by (1)
-
24
- O6-methyl-guanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course
-
WATANABE T
Int J Cancer 113, 581-587, 2005
Cited by (1)
-
25
- Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
-
HEGI ME
J Clin Oncol 26, 4189-4199, 2008
Cited by (1)
-
26
- The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas
-
CAO VT
Neurosurgery 65, 866-875, 2009
Cited by (1)
-
27
- DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma
-
FRIEDMAN HS
J Clin Oncol 16, 3851-3857, 1998
Cited by (1)
-
28
- Heterogeneity in the expression of markers for drug resistance in brain tumors
-
ANDERSSON U
Clin Neuropathol 23, 21-27, 2004
Cited by (1)
-
29
- Long-term survival in patients with glioblastoma multiforme
-
CHANDLER K.
Neurosurgery 32, 716-720, 1993
DOI Cited by (6)
-
30
- Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
STUPP R
N Engl J Med 352, 987-996, 2005
DOI Cited by (13)
-
31
- MGMT gene silencing and benefit from temozolomide in glioblastoma
-
HEGI ME
N Engl J Med 352, 997-1003, 2005
DOI Cited by (6)
-
32
- Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene
-
WATTS GS
Mol Cell Biol 17, 5612-5619, 1997
Cited by (5)
-
33
- Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
-
ESTELLER M
New Engl J Med 343, 1350-1354, 2000
DOI Cited by (16)
-
34
- Prognostic significance of the immunohistochemical expression of O(6)-methyl-guanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas
-
NAKAGAWA T
Neuropathology 29, 379-388, 2009
Ichushi Web Cited by (2)
-
35
- Inter- and intracellular heterogeneity of O6-alkylguanine-DNA alkyltransferase expression in human brain tumors : possible significance in nitrosourea therapy
-
LEE SM
Carcinogenesis 17, 637-641, 1996
Cited by (1)
-
36
- MGMT immunohistochemical expression and promoter methylation in human glioblastoma
-
RODRIGUEZ FJ
Appl Immunohistochem Mol Morphol 16, 59-65, 2008
Cited by (2)
-
37
- Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
-
HEGI ME
Clin Cancer Res 10, 1871-1874, 2004
DOI Cited by (3)
-
38
- Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide
-
NAGANE M
Jpn J Clin Oncol 37, 897-906, 2007
Ichushi Web Cited by (1)
Cited by: 1
-
1
- IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas
-
SHIBAHARA Ichiyo , SONODA Yukihiko , KANAMORI Masayuki , SAITO Ryuta , YAMASHITA Yoji , KUMABE Toshihiro , WATANABE Mika , SUZUKI Hiroyoshi , KATO Shunsuke , ISHIOKA Chikashi , TOMINAGA Teiji
International journal of clinical oncology 17(6), 551-561, 2012-12-01
Ichushi Web References (33)